Medical hypotheses2021,Vol.1461.DOI:10.1016/j.mehy.2020.110466

Peptidyl arginine deiminase 4 and its potential role in Alzheimer's disease

Wang, Li-ling Song, Ye-ping Mi, Jian-hua Ding, Meng-lei
Medical hypotheses2021,Vol.1461.DOI:10.1016/j.mehy.2020.110466

Peptidyl arginine deiminase 4 and its potential role in Alzheimer's disease

Wang, Li-ling 1Song, Ye-ping 1Mi, Jian-hua 1Ding, Meng-lei2
扫码查看

作者信息

  • 1. Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Neurol, Shanghai 201100, Peoples R China
  • 2. Tongji Univ, Shanghai East Hosp, Sch Med, Dept Clin Lab, Shanghai 200120, Peoples R China
  • 折叠

Abstract

Alzheimer's disease (AD) is the main cause of dementia, and its pathogenesis is still not clear. Peptidyl arginine deiminases 4(PAD4) as one of the important members of PAD family, is the only protein with nuclear transfer function, it can regulate the expression of many proteins through citrullinating histone. PAD4 can also interact with many transcription factors, involved in regulating gene expression. PAD4 expression is closely related to the inflammatory factors secreted, cell autophagy, tumorigenesis and other neurodegenerative diseases. More importantly, PAD4 and its citrullinated protein were found in cortical and hippocampal neurons of AD patients. To study the expression and regulatory pathway of PAD4 in vivo and in vitro experiments on AD may be of helpful to elucidate the pathogenesis of AD. Meanwhile, detection of anti-citrullinated antibody will have potential value as novel biomarkers of AD.

Key words

Peptidyl arginine deiminases 4/Citrullination/Autoantibodies/Alzheimer disease

引用本文复制引用

出版年

2021
Medical hypotheses

Medical hypotheses

SCI
ISSN:0306-9877
被引量3
参考文献量56
段落导航相关论文